AUTHORS
Suruchi Garg, Navnee Jain, Carol Lobo
ABSTRACT
Hair loss, particularly androgenetic alopecia (AGA) and female pattern hair loss (FPHL), is a common dermatologic concern with significant impact on the quality of life and psychosocial well-being of patients. Although current FDA approved therapies such as minoxidil, finasteride and low-level laser therapy can slow progression and promote modest regrowth, their use is often limited by poor compliance, adverse effects and need for long term use.
Learn more about the MCT System: MCT Plasma | MCT Exosomes | Exo-Tech

